Wuxi School of Medicine, Jiangnan University, 1800 Lihudadao, Wuxi, 214122, Jiangsu Province, China.
Department of Urology, Affiliated Hospital of Jiangnan University, 1000 Hefeng Road, Wuxi, 214122, Jiangsu Province, China.
Curr Cancer Drug Targets. 2024;24(5):477-489. doi: 10.2174/0115680096262439231023110106.
Vasodilator-stimulated phosphoprotein (VASP) is an actin-binding protein that includes three structural domains: Enabled/VASP homolog1 (EVH1), EVH2, and proline-rich (PRR). VASP plays an important role in various cellular behaviors related to cytoskeletal regulation. More importantly, VASP plays a key role in the progression of several malignant tumors and is associated with malignant cell proliferation, invasion, and metastasis. Here, we have summarized current studies on the impact of VASP on the development of several malignant tumors and their mechanisms. This study provides a new theoretical basis for clinical molecular diagnosis and molecular targeted therapy.
血管扩张刺激磷蛋白(VASP)是一种肌动蛋白结合蛋白,包含三个结构域:Enabled/VASP 同源物 1(EVH1)、EVH2 和富含脯氨酸(PRR)。VASP 在与细胞骨架调节相关的各种细胞行为中发挥着重要作用。更重要的是,VASP 在几种恶性肿瘤的进展中起着关键作用,与恶性细胞增殖、侵袭和转移有关。在这里,我们总结了 VASP 对几种恶性肿瘤发展的影响及其机制的最新研究。本研究为临床分子诊断和分子靶向治疗提供了新的理论依据。